Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor Manuel Orellana-Noia, Daniel R. Reed, Ashley Alesia McCook, Jeremy Michael Sen, Christian M. Barlow, Mary-Kate Malecek, Marcus Watkins, Brad S. Kahl, Michael A. Spinner, Ranjana Advani, Timothy J. Voorhees, Anson Snow, Natalie Sophia Grover, Amy Ayers, Jason Romancik, Yuxin Liu, Scott F. Huntington, Julio C. Chavez, Hayder Saeed, Aleksandr Lazaryan, Vikram Raghunathan, Stephen E. Spurgeon, Thomas A. Ollila, Christopher Del Prete, Adam Olszewski, Emily C. Ayers, Daniel J. Landsburg, Benjamin Echalier, Jun Lee, Manali Kamdar, Paolo F. Caimi, Timothy Fu, Jieqi Liu, Kevin A. David, Hanan Alharthy, Jennie Law, Reem Karmali, Harsh Shah, Deborah M. Stephens, Ajay Major, Alexandra E. Rojek, Sonali M. Smith, Amulya Yellala, Avyakta Kallam, Shazi Nakhoda, Nadia Khan, Mohammad Ahsan Sohail, Brian T. Hill, Odeth Barrett-Campbell, Frederick Lansigan, Jeffrey Switchenko, Jonathon Cohen, Craig A. Portell

Blood (2022) 139 (3): 413–423.

https://doi.org/10.1182/blood.2021012888

Published: 2022

Includes: Supplemental data

Journal Articles

An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission

Daniel M Guidot, MPH, Jeffrey Switchenko, PhD, Loretta J. Nastoupil, MD, Jean L. Koff, MD, Christopher Flowers, MD MS, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 1799.

https://doi.org/10.1182/blood.V128.22.1799.1799

Published: 2016

Journal Articles

Use of Metabolic Tumor Volume (MTV) in Patients with Mantle Cell Lymphoma

Daniel M Guidot, MPH, Ila Sethi, MD, Jeffrey Switchenko, PhD, Daniel Lee, MD, Loretta J. Nastoupil, MD, Jean L. Koff, MD, Christopher Flowers, MD MS, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 5321.

https://doi.org/10.1182/blood.V128.22.5321.5321

Published: 2016

Journal Articles

Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant

Abigail G Kettle, Jeffrey Switchenko, PhD, Oscar Calzada, BS, Anh Thuy Phan, MPH, Monique Farone, MPH, Michael Graiser, PhD, Christopher R. Flowers, MD, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 5825.

https://doi.org/10.1182/blood.V128.22.5825.5825

Published: 2016

Journal Articles

CD30 Expression Is Not Acquired at Time of Relapse in Diffuse Large B-Cell Lymphoma

Oscar Calzada, BS, Kyle T. Bradley, MD MS, Jeffrey Switchenko, PhD, Ashley D. Staton, MD, Jean L. Koff, MD, Christopher R. Flowers, MD, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 4225.

https://doi.org/10.1182/blood.V128.22.4225.4225

Published: 2016

Journal Articles

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

Michael Jinpyo Lee, B.S., Jeffrey Switchenko, PhD, Janeen S Thomas, Jean L. Koff, MD, Loretta Nastoupil, MD, Mary Jo Lechowicz, MD, Amelia A Langston, MD, Christopher Flowers, MD, Jonathon B. Cohen, MD

Blood (2015) 126 (23): 5095.

https://doi.org/10.1182/blood.V126.23.5095.5095

Published: 2015

Journal Articles

A Phase II Trial of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent Non-Hodgkin’s Lymphoma

Jonathon B. Cohen, MD, Jeffrey Switchenko, PhD, Jean L. Koff, MD, Rajni Sinha, MD MRCP, Jonathan L. Kaufman, MD, H. Jean Khoury, MD FACP, Nassoma K Bumpers, PA, Amanda Colbert, Amanda A Hutchison-Rzepka, BA, Loretta J. Nastoupil, MD, Leonard T. Heffner, MD, Amelia Langston, MD, Mary Jo Lechowicz, MD, Sagar Lonial, MD, Christopher R. Flowers, MD

Blood (2014) 124 (21): 4432.

https://doi.org/10.1182/blood.V124.21.4432.4432

Published: 2014

Journal Articles

Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation

Hyun Don Yun, MD, Tehseen Dossul, BA, Leon Bernal-Mizrachi, MD, Jeffrey Switchenko, PhD, Chukwuma Ndibe, MD, Abiola Ibraheem, MD, Amelia Langston, MD, Rebecca Pentz, PhD, Edmund K. Waller, MD PhD

Blood (2014) 124 (21): 6002.

https://doi.org/10.1182/blood.V124.21.6002.6002

Published: 2014

Journal Articles

Spatial Epidemiology Of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma In The State Of Georgia

Catherine Bulka, MPH, Loretta J. Nastoupil, MD, Jeffrey Switchenko, PhD, Kevin Ward, PhD, MPH, CTR, Rana Bayakly, MPH, Lance Waller, PhD, Christopher R. Flowers, MD

Blood (2013) 122 (21): 1683.

https://doi.org/10.1182/blood.V122.21.1683.1683

Published: 2013

Journal Articles

Relationship Between Residential Proximity To Environmental Protection Agency (EPA) Designated Toxic Release Sites and The Risk Of Diffuse Large B-Cell Lymphoma (DLBCL)

Catherine Bulka, MPH, Loretta J. Nastoupil, MD, Jean Koff, MD, Leon Bernal, MD, Kevin Ward, PhD, MPH, CTR, Rana Bayakly, MPH, Jeffrey Switchenko, PhD, Lance Waller, PhD, Christopher R. Flowers, MD

Blood (2013) 122 (21): 1684.

https://doi.org/10.1182/blood.V122.21.1684.1684

Published: 2013

Journal Articles

Integrative, Multi-Platform, Whole-Genome Analyses Identify Clinically Relevant Common- and Cell-Specific Signatures in Multiple Myeloma

Jeanne Kowalski, PhD, Khanjan Gandhi, MS, Jeffrey Switchenko, PhD, Yuan Liu, PhD, Sungjin Kim, MS, Gregory Doho, MS, Seung J Kim, Rendong Yang, PhD, Li Chen, MS, Zhaohui Qin, PhD, Scott Newman, PhD, Carlos S Moreno, Ph.D., Paula M Vertino, PhD, Leon Bernal-Mizrachi, M.D., Michael R Rossi, PhD, Sagar Lonial, MD, Lawrence H. Boise, PhD

Blood (2012) 120 (21): 3974.

https://doi.org/10.1182/blood.V120.21.3974.3974

Published: 2012

NARROW

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission

Use of Metabolic Tumor Volume (MTV) in Patients with Mantle Cell Lymphoma

Prolonged Progression-Free Survival Is Possible in Patients with Diffuse Large B-Cell Lymphoma Receiving > 1 Salvage Therapies before Autologous Stem Cell Transplant

CD30 Expression Is Not Acquired at Time of Relapse in Diffuse Large B-Cell Lymphoma

Complex Karyotype in Mantle Cell Lymphoma (MCL) Is Associated with Inferior Progression-Free Survival in Patients (pts) Receiving R-Hypercvad Followed By Autologous Stem Cell Transplant

A Phase II Trial of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent Non-Hodgkin’s Lymphoma

Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation

Spatial Epidemiology Of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma In The State Of Georgia

Relationship Between Residential Proximity To Environmental Protection Agency (EPA) Designated Toxic Release Sites and The Risk Of Diffuse Large B-Cell Lymphoma (DLBCL)

Integrative, Multi-Platform, Whole-Genome Analyses Identify Clinically Relevant Common- and Cell-Specific Signatures in Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only